Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice.
Nat Commun. 2021 Dec 8;12(1):7101. doi: 10.1038/s41467-021-26714-w.
Nat Commun. 2021.
PMID: 34880218
Free PMC article.